FAF May Help Determine Need for Additional PRP in Proliferative DR

Study finds partially preserved photoreceptor integrity and sensitivity even in laser-treated areas of the retina.

UWF-FA Reveals DR Progression Associated with Nonperfusion

Neovascularization, however, was less strongly correlated with disease advancement in a large retrospective review of over one thousand images.

MD Groups Respond to Study Linking GLP-1 Treatment to NAION

The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.

Popular Type 2 Diabetes Drug Associated with Increased Risk of NAION

Though causality could not be determined, researchers observed a higher incidence of the event among patients on GLP-1 receptor agonists than those taking other diabetes or weight loss medications.

Over Four Million People Globally Experience Vision Impairment from DR

One-quarter of those affected are now blind, says a new meta-analysis. Prevalence is disproportionately higher in low-income regions and female populations.

Meta-analysis Says Oral Hypoglycemic Not Clearly Linked to Increased DR Risk

Studies on dipeptidyl peptidase-4 inhibitor use showed conflicting evidence and, ultimately, no significant change in risk or progression in patients with diabetes.

Controlling Hypertension Could Help Delay DR

A small study found that high blood pressure plays a large role in driving retinal arteriolar wall thickening in preclinical diabetic retinopathy.

Study Documents Increased DR Prevalence in Young Patients and Minorities

People aged 20 to 39 and those in Hispanic or Black ethnic/racial groups were most acutely affected, supporting the need for DR screening in young adults.

Diabetic Eye Disease: A Comprehensive Look at the Optometrist’s Role

Learn what to pay attention to and when to take charge.

Type 2 Diabetes Drug May Reduce RVO Risk

Compared with DPP-4i, patients taking SGLT-2i had a significantly lower incidence of retinal vein occlusion, particularly branch RVO.

Upcoming Events

July 24, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Jade Coats, OD, and Neel Vaidya, MD, MPH
Webinar: 9:00pm ET

Sponsored by Bausch + Lomb

Register here

August 14, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters:  Mark Dunbar, OD, FAAO, and David Chin Yee, MD
Webinar: 8:30pm ET

Sponsored by Apellis

Register here

August 20, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Joshua Davidson, OD, and Zaina Al-Mohtaseb, MD
Webinar: 8:00pm ET

Sponsored by Bausch + Lomb

Register here